Intravital Microscopy in Human Solid Tumors

NCT03823144 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 85

Last updated 2025-12-11

No results posted yet for this study

Summary

This study will investigate the tumor-associated vasculature of patients with solid tumors. The investigators will use a technology known as intravital microscopy (IVM) in order to visualize in real-time the vessels associated with solid tumors. The IVM observations may determine if an individual patient's tumor vessels would be amenable to receiving systemic therapy, based on the functionality of the vessels.

Conditions

  • Solid Tumor, Adult
  • Clinical Stage IV Gastric Cancer AJCC v8
  • Malignant Solid Neoplasm
  • Metastatic Colorectal Carcinoma
  • Metastatic Gastric Carcinoma
  • Metastatic Primary Malignant Brain Neoplasm
  • Metastatic Sarcoma
  • Postneoadjuvant Therapy Stage IV Gastric Cancer AJCC v8
  • Resectable Colorectal Carcinoma
  • Resectable Liver and Intrahepatic Bile Duct Carcinoma
  • Resectable Pancreatic Carcinoma
  • Resectable Sarcoma
  • Stage IV Colorectal Cancer AJCC v8
  • Anatomic Stage IV Breast Cancer AJCC v8
  • Malignant Brain Neoplasm
  • Metastatic Breast Carcinoma
  • Metastatic Liver Carcinoma
  • Metastatic Pancreatic Carcinoma
  • Resectable Brain Neoplasm
  • Resectable Breast Carcinoma
  • Resectable Gastric Carcinoma
  • Stage IV Hepatocellular Carcinoma AJCC v8
  • Stage IV Pancreatic Cancer AJCC v8

Interventions

DEVICE

Diagnostic Microscopy

Undergo Intravital microscopy (IVM), which allows real-time, direct visualization of microscopic blood vessels and calculation of blood flow.

DRUG

Fluorescein Sodium Injection

Given IV as part of IVM procedure

Sponsors & Collaborators

Principal Investigators

  • Emmanuel M Gabriel, M.D., Ph.D. · Mayo Clinic

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-28
Primary Completion
2026-09-30
Completion
2026-09-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03823144 on ClinicalTrials.gov